评估一种可翻译的基于网络的干预措施,以增加癌症幸存者的身体活动:试点随机试验
Jessica L Unick1,2, Christine Duffy2,3,4, Don Dizon2
1Weight Control and Diabetes Research Center, Miriam Hospital, 196 Richmond St, Providence, RI, 02903, United States, 1 4017938966.
JMIR cancer
|October 2, 2025
概括
在癌症幸存者中,自动化炼计划显著增加了中度至强度的体力活动 (MVPA). 这种干预证明是可行的和可接受的,为管理长期健康挑战提供了一个有希望的方法.
科学领域:
- 在瘤学瘤学.
- 运动科学 运动科学
- 数字健康数字健康
背景情况:
- 癌症幸存者经历治疗后的长期健康问题.
- 身体活动 (PA) 有助于管理副作用,但坚持是低的 (80%不符合指导方针).
- 癌症幸存者需要有效和可扩展的PA干预措施.
研究的目的:
- 评估一个为期12周的自动互联网程序 (Energize!) 的可行性,可接受性和初步有效性. 在癌症幸存者中增加中度至强度的体力活动 (MVPA).
- 检查干预对身体和精神健康的影响.
- 将自动化程序与接受教育通讯的对照组进行比较.
主要方法:
- 随机试验涉及不活跃的癌症幸存者随机分配到Energize! 计划或新闻通讯的控制组.
- 充满活力! 充满活力! 计划:自动化,每周视频课程,家庭作业,运动计划,渐进的MVPA目标 (每周75-200分钟),以及个性化的反.
- 评估:基线,3个月 (干预后) 和6个月. 测量可行性 (入学,留学),可接受性 (参与,满意度),MVPA (自我报告,加速度计) 和健康结果 (生活质量,疲劳,痛苦).
主要成果:
- 高可行性 (69%的入学率) 和保留率 (94%在6个月).
- 高接受度:高参与度指标 (例如,观看了87.7%的课程) 和对Energize!更高的满意度. 我们的VS. 新闻通讯 (5.8对 3.2).
- 充满活力! 充满活力! 3个月后,自我报告的MVPA (92.7分钟/周),发作MVPA (35.4分钟/周) 和总MVPA (46.3分钟/周) 显著增加,并在6个月后进行部分维护. 在通讯小组中观察到适度增加.
结论:
- 这是一个自动化的Energize! 该计划是增加癌症幸存者的MVPA的可行和可接受的干预措施.
- 研究结果表明,自主导的PA程序可以对改善该群体的MVPA有益.
- 需要未来的研究来优化长期的MVPA遵守.
相关概念视频
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


